Recombinant Human HLA-B*40:01&B2M Monomer Protein (HEK293)，Avi & His

HLA-B*40:01 is a specific allele of the human leukocyte antigen (HLA) class I molecule, which plays a crucial role in the immune response by presenting peptides to T cells. Understanding the structural and functional characteristics of HLA-B*40:01, particularly when complexed with β2-microglobulin (B2M), is essential for elucidating its involvement in various diseases, including autoimmune disorders and responses to infectious diseases. The recombinant production of the HLA-B*40:01/B2M monomer enables researchers to analyze its binding affinity, peptide presentation capabilities, and overall stability. Such studies are vital for exploring its implications in transplant immunology, vaccine development, and the design of targeted therapies. By investigating the interactions between this HLA molecule and its associated peptides, researchers aim to uncover mechanisms underlying individual differences in immune responses and susceptibility to diseases, paving the way for personalized medicine approaches. Additionally, the HLA-B*40:01/B2M monomer serves as a valuable tool for developing diagnostic and therapeutic interventions by enhancing our understanding of T cell receptor interactions and the overall dynamics of the immune system. Thus, the study of this recombinant protein stands at the intersection of immunology, molecular biology, and clinical research, contributing to a deeper comprehension of human health and disease.